Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.

作者: Ronald J. Trent , Pak Leng Cheong , Eng Wee Chua , Martin A. Kennedy

DOI: 10.1097/PAT.0B013E328360B66E

关键词: Human genetic variationPharmacologyIdentification (biology)EfficacyPharmacogeneticsBioinformaticsGenetic testingDrugPharmacogenomicsMolecular diagnosticsMedicine

摘要: Summary Understanding human genetic variation and how it impacts on gene function is a major focus in genomic-based research. Translation of this knowledge into clinical care exemplified by pharmacogenetics/pharmacogenomics. The identification particular variants that might influence drug uptake, metabolism, distribution or excretion promises more effective personalised medicine approach choosing the right its dose for any individual. Adverse responses can then be avoided mitigated. An understanding germline acquired (somatic) DNA mutations also used to identify drugs are likely therapeutically beneficial. This represents an area growing interest treatment cancer.

参考文章(80)
Jean-Sébastien Hulot, Jean-Philippe Collet, Johanne Silvain, Ana Pena, Anne Bellemain-Appaix, Olivier Barthélémy, Guillaume Cayla, Farzin Beygui, Gilles Montalescot, Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration: A Systematic Meta-Analysis Journal of the American College of Cardiology. ,vol. 56, pp. 134- 143 ,(2010) , 10.1016/J.JACC.2009.12.071
TE Klein, RB Altman, Niclas Eriksson, BF Gage, SE Kimmel, MT Lee, NA Limdi, D Page, DM Roden, MJ Wagner, MD Caldwell, JA Johnson, YT Chen, MS Wen, Y Caraco, I Achache, S Blotnick, M Muszkat, JG Shin, HS Kim, G Suarez-Kurtz, JA Perini, E Silva-Assuncao, JL Anderson, BD Horne, JF Carlquist, RL Berg, JK Burmester, BC Goh, SC Lee, F Kamali, E Sconce, AK Daly, AH Wu, TY Langaee, H Feng, L Cavallari, K Momary, M Pirmohamed, A Jorgensen, CH Toh, P Williamson, H McLeod, JP Evans, KE Weck, C Brensinger, Y Nakamura, T Mushiroda, D Veenstra, L Meckley, MJ Rieder, AE Rettie, M Wadelius, H Melhus, CM Stein, U Schwartz, D Kurnik, E Deych, P Lenzini, C Eby, LY Chen, P Deloukas, A Motsinger-Reif, H Sagreiya, BS Srinivasan, E Lantz, T Chang, M Ritchie, LS Lu, Estimation of the warfarin dose with clinical and pharmacogenetic data The New England Journal of Medicine. ,vol. 360, pp. 753- 764 ,(2009) , 10.1056/NEJMOA0809329
Michiko AIHARA, Pharmacogenetics of cutaneous adverse drug reactions Journal of Dermatology. ,vol. 38, pp. 246- 254 ,(2011) , 10.1111/J.1346-8138.2010.01196.X
Joan S. McClure, Evidence and Insights in the NCCN Guidelines Journal of The National Comprehensive Cancer Network. ,vol. 10, pp. 427- 429 ,(2012) , 10.6004/JNCCN.2012.0043
Matthew W. Anderson, Iris Schrijver, Next generation DNA sequencing and the future of genomic medicine. Genes. ,vol. 1, pp. 38- 69 ,(2010) , 10.3390/GENES1010038
M V Relling, T E Klein, CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network Clinical Pharmacology & Therapeutics. ,vol. 89, pp. 464- 467 ,(2011) , 10.1038/CLPT.2010.279
S G Leckband, J R Kelsoe, H M Dunnenberger, A L George, E Tran, R Berger, D J Müller, M Whirl-Carrillo, K E Caudle, M Pirmohamed, Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and carbamazepine dosing Clinical Pharmacology & Therapeutics. ,vol. 94, pp. 324- 328 ,(2012) , 10.1038/CLPT.2013.103
D Gurwitz, J E Lunshof, G Dedoussis, C S Flordellis, U Fuhr, J Kirchheiner, J Licinio, A Llerena, V G Manolopoulos, L J Sheffield, G Siest, F Torricelli, V Vasiliou, S Wong, Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education. Pharmacogenomics Journal. ,vol. 5, pp. 221- 225 ,(2005) , 10.1038/SJ.TPJ.6500312